Search
for
Sort by
Research 601–630 of 1000+
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Actions of 5α-reductase inhibitors on the epididymis
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
- Classic versus non‐classic: A survival Kit for life in the skin
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- A selection of eleven plants used as traditional Polynesian cosmetics and their development potential as anti-aging ingredients, hair growth promoters and whitening products
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Mechanotransduction unifies healthy non-diabetic wound healing over time by promoting a Cd14+/C1qa+ fibroblast subpopulation
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extract